Tolero Pharmaceuticals is a clinical stage biopharmaceutical company developing treatments to improve and extend the lives of patients with serious oncological and hematological diseases. Our diverse pipeline targets important biological drivers of blood disorders to treat leukemias and anemia as well as important targets of drug resistance and transcriptional control.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/08/14 | $14,200,000 | Series B |
Fred Alger Management | undisclosed |
| 11/07/14 | $8,200,000 | Series B |
Fred Alger Management | undisclosed |
